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Abstract
Background: Mental health is increasingly finding a place on global health and international development agendas.
Advocates for Global Mental Health (GMH), and international organizations such as the World Health
Organization (WHO) and the World Bank, argue that treatments available in high-income countries should also be
made available in low- and middle-income countries. Such arguments are often made by comparing mental health to
infectious diseases, including the relative disease and economic burdens they impose, and pointing to the applicability
of the right to access treatment for mental health, not only infectious diseases. HIV/AIDS advocacy in particular has
been held up by GMH advocates as offering an appropriate strategy for generating global commitment.
Discussion: There is a need to assess how health issues are framed not only in relation to social goods outside of
health (such as human rights, security or development), but also in relation to other health or disease models, and how
health policy and practice is shaped as a result. The article debates the merits and consequences of likening mental
health to HIV/AIDS, and identifies four major problems with the model for GMH advocacy being developed through
these analogies: 1. An inappropriately universalizing global approach to context-specific problems; 2. A conception of
human rights that focuses on the right to access treatment at the expense of the right to refuse it; 3. A tendency to
treat poverty as a psychiatric issue, rather than recognizing that mental distress can be the result of poverty and other
forms of inequality; 4. The prioritization of destigmatization of disease over social justice models.
Conclusion: There are significant problems with the wholesale adoption of an (often simplified) version of HIV/AIDS
advocacy as a model for GMH. Yet critical engagement with the important and nuanced differences between HIV/AIDS
and mental health may nevertheless point to some possibilities for productive engagement and cross-fertilisation
between advocates, activists and scholars in both fields.
Keywords: Global mental health, HIV/AIDS, International development, Global public health policy, Human rights,
Medicalization
Background
In recent years, the ‘Movement for Global Mental
Health’ (MGMH) and international organizations such
as the World Health Organization and the World Bank
have put forward a case that ‘mental health is not only
relevant to global health…but in fact lies at its very
heart’ [1]. Global Mental Health (GMH) advocates have
seen considerable success. For example, mental health is
now included in the UN Sustainable Development Goals
(SDGs) under Target 3.4 [2]. Key to this success has
been the claim that mental health can and should be
framed as a global health challenge similar to infectious
disease, particularly HIV/AIDS. This comparison has
been pursued in at least two ways.
Firstly, GMH advocates have compared both the dis-
ease burden and the economic burden of mental health
to those of infectious disease, arguing that in compari-
son to infectious disease mental health is an even more
pressing global problem. Secondly, GMH advocates have
sought to learn from the success of HIV/AIDS advocacy,
arguing that they should utilize similar strategies to gain
attention and resources. They have argued that mental
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health should be framed as a truly ‘global’ problem, that
an ethical case for the right to access to treatment in
low and middle-income countries (LMICs) should be
made, and that mental health should be a central goal
within global health and development.
In this article, we raise the need for greater debate
over the merits of this framing. We argue that GMH ad-
vocates are modelling advocacy on a selective and over-
simplified version of the history of HIV/AIDS advocacy,
and ignoring significant problems that result from falsely
treating mental health and infectious disease as if they
represent similar kinds of problem. We also suggest,
however, that a more nuanced reading of the history of
HIV/AIDS advocacy, which pays attention to its strug-
gles and not only its successes, could provide some use-
ful lessons for GMH advocates. In order to set the
background for this debate, we begin with an account of
the modeling of GMH advocacy on HIV/AIDS advocacy.
Modeling GMH on HIV/AIDS advocacy: a brief history
HIV/AIDS has been the most prominent global health
issue over the last 25 years and has captured the largest
slice of development assistance for health. Effective ad-
vocacy has been crucial in generating this success [3–5].
AIDS activists from the early 1980s onwards famously
fought stigma and discrimination, argued for a human
right to access treatment, and called on governments in
both the Global North and the Global South to increase
their efforts to tackle the pandemic.
GMH advocates want to replicate this history in their
own field. They have urged governments across the
world - especially in LMICs- to take mental health more
seriously, to agree there is ‘no health without mental
health’ [6], and to scale up access to mental health ser-
vices [7]. At the heart of current calls to ‘Mainstream
mental health interventions into health, poverty reduc-
tion, development policies, strategies and interventions’
[8, 9] is the argument that, like HIV/AIDS, poor mental
health is not only detrimental to individual wellbeing,
but also to international development [9].
GMH advocates frequently make explicit comparisons
between mental health and infectious diseases, especially
HIV/AIDS. They argue that mental health occupies a
low priority for policy makers and donors, compared to
communicable diseases linked to premature mortality,
and particularly to HIV/AIDS [10] despite estimates that
‘mental disorders’ contribute more than infectious dis-
eases to the global burden of disease [9]. On this basis,
‘mental illnesses’ are presented as ‘killer diseases’ that
‘need to take their place among the other killer diseases
for investment and priority’ [11]. As well as comparing
disease burden, the economic burden of (and return on
investment in) mental health and communicable dis-
eases (including HIV/AIDS) are often compared [12]. It
has been argued that treatment for mental disorders is
as cost-effective as antiretroviral treatment for HIV/
AIDS [13, 14], and that investment in addressing men-
tal health generates returns commensurate with invest-
ment in diseases such as HIV/AIDS [15].
As well as comparing mental health to HIV/AIDS,
GMH advocacy has explicitly modeled itself on the suc-
cess of HIV/AIDS advocacy. The Overseas Development
Institute notes in a 2014 report that ‘The HIV/AIDS
movement has made enormous progress in capturing
policy-makers’ attention, attracting funding to the issue
and helping to overcome associated stigma’ [16]. Gostin
states that lack of social mobilization within GMH advo-
cacy accounts for the ‘incommensurate response to
mental illness when compared with HIV/AIDS’ [17].
Burns enjoins ‘the mental health community – both pro-
fessional and lay… to take a leaf out of the HIV/AIDS
advocacy movement’s book and mobilise itself into a
high-profile, populist force to be reckoned with. Mental
illness and its service-related needs must be thrust into
the public eye as a major issue which, if ignored, will
threaten the well-being of society in all its facets – social,
economic and political’ [18]. Kleinman calls for ‘recogni-
tion that any effective change in global mental health will
have to prioritise moral transformation as the foundation
for reform of global mental health, much as it was for the
reform that spurred HIV/AIDS treatment in Africa and
Asia’ [19].
It should be noted that although the MGMH claims
the title of a singular ‘movement’ there is a trifurcation
in the global mental health field. There is the MGMH,
which, while largely originating from professional-led
advocacy, now includes members who identify as psy-
chosocially disabled and global NGO members. There
are also those organizations that advocate for global
mental health in a related but distinct sense from the
‘Movement’, such as the WHO and the World Bank. Fi-
nally, there are organized movements of activists composed
especially of users/survivors of psychiatric systems, and
‘Mad Pride’ activists, who organize across national borders
to resist the over-extension of psychiatric power, connect-
ing psychiatry’s colonial history with contemporary for-
warding of western psychiatric ‘solutions’ as appropriate in
LMICs. Examples include Transforming Communities for
Inclusion, the World Network of Users and Survivors of
Psychiatry, and MindFreedom, amongst others. Although
there is some overlap between these three areas of action,
we refer to the MGMH (in relation to the first type of
advocacy), to GMH advocacy (to refer to a wider
mobilization, including the WHO) and to user/survivor
activists in reference to the third kind of action. While
the MGMH and other GMH advocates have proposed
HIV/AIDS advocacy as a model for securing resources
for mental health, user/survivor activists have not
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generally pursued this line of argument precisely because
they often resist the furthering of Western medical models
of ‘mental illness’ globally.
The remainder of this article presents a debate on four
potential pitfalls of comparing HIV/AIDS and mental ill-
ness and/or adopting the model of HIV/AIDS advocacy
in GMH advocacy (especially in an over-simplified form),
while also pointing to some possibilities for more product-
ive engagement between advocates, activists, and scholars
in both fields.
Discussion
Recent successes in getting mental health on the global
health and international development agendas have relied
on the two-pronged strategy of:
1. likening mental health to infectious disease and;
2. explicitly modeling GMH advocacy on HIV/AIDS
advocacy.
Now that mental health is increasingly on the agenda
(for example, in the SDGs), GMH advocates continue to
use these strategies to push for attention and resources.
Learning from previously successful advocacy movements
might seem to be a sensible approach. However, claiming
HIV/AIDS as a model for global mental health advocacy
raises potential problems.
As regards the first prong, we argue that infectious
disease and mental health involve differing political and
ethical issues that limit how far comparisons can be
made between one and the other. The problems with
this comparison only grow worse when the diverse class
of experiences referred to as mental illness is compared
to a single infectious disease like HIV/AIDS.
As regards the second prong, we argue that the compar-
isons that are drawn between GMH advocacy on the one
hand, and HIV/AIDS advocacy on the other, whilst super-
ficially plausible, are often based on ‘broad brush’ simplifi-
cations or misconstructions of the history of HIV/AIDS
advocacy. There is a tendency to overlook important re-
cent developments in the HIV/AIDS field– in particular
the move away from seeing HIV/AIDS as a single ‘global’
problem towards focusing instead on the local contexts in
which the disease is contracted.
Given these problems, it is timely and essential to con-
sider what, if any, lessons should be learned by GMH
advocates from HIV/AIDS. In particular, we argue that
paying more attention to the struggles of HIV/AIDS ad-
vocacy as well as to its successes may be particularly
useful.
In considering this comparison, we build upon work
that has examined the different ways in which health is-
sues have been ‘framed’ to capture political attention
and resources. ‘Framing’ is of vital importance to the
construction of global priorities, and for how global pub-
lic health is defined and delivered [20–22]. Scholars have
noted that global health issues have been variously
framed in terms of human rights [23], international se-
curity [24–30], international development [31], or in
terms of evidence-based medicine [32]. Here we seek to
extend this analysis to examine not only how health is
framed in relation to external goods (human rights, se-
curity, etc), but also to examine how health issues have
been framed in relation to each other: in this case, how
mental health is framed in relation to HIV/AIDS.
We outline four key problems with the model of GMH
advocacy that is being developed through these analogies:
1. Issues with a universalizing global approach to context-
specific problems; 2. Issues with a conception of human
rights that focuses on the right to access treatment at the
expense of the right to refuse it; 3. Issues with treating
poverty as a psychiatric issue, rather than recognizing that
mental distress can be the result of poverty and other
forms of inequality; 4. The prioritization of destigmatiza-
tion of disease over anti-discrimination or social justice
models.
Mental health as a ‘global’ problem: learning from HIV/AIDS
advocacy
AIDS has been credited with having ‘invented’ global
health, building ‘the foundation for a revolution that
upended traditional approaches to “international health,”
replacing them with innovative global approaches to dis-
ease’ [33]. Certainly the rise of global health as a policy
field has been closely related to the rise in political com-
mitment to tackling HIV/AIDS. Crucial to the gener-
ation of that political commitment was the argument
that HIV/AIDS was a genuinely global challenge, affect-
ing rich and poor societies alike, for which the solutions
needed to be similarly global. In the same way, those ad-
vocating for GMH conceptualise mental disorders as
‘truly universal…found in people of all regions…at all
stages of the life course’ [8], indeed that ‘mental health
problems are extremely common in all countries of the
world’ [34].
This framing of ‘mental health’ as a global problem is
premised on the notion that there is universal consensus
on what constitutes a ‘mental disorder’, and on diagnos-
tic criteria; that mental distress is an ‘illness’; that the
prevalence of mental disorders can be objectively measured
in a similar way to infectious disease; and that the multipli-
citous field covered by ‘mental illness’ is susceptible to be-
ing tackled by a unified strategy. Yet no such global
consensus exists on these premises [35–38].
Whilst there are certain diagnostic models that purport
to be authoritative (most notably, the Diagnostic and Stat-
istical Manual - DSM; and the International Classification
of Mental and Behavioral Disorders - ICD) even these
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function as a regularly-revised summary of often sharp
professional disagreements about what should be included
and how it should be defined, rather than a stable con-
sensus. Consensus groups have been formed for a number
of mental disorders (namely ADHD and Depression). Yet
these have been critiqued for being influenced by the
pharmaceutical industry [39], and for forestalling debate
about the validity of various diagnoses, cultural construc-
tions of ‘normal’ behaviour, global applicability of diagnos-
tic systems, and the efficacy of treatment [37]. Attempts at
international consensus often overlook widespread con-
cerns about the deleterious effects of prolonged use of
psychotropic drugs - the hallmark of current bio-medical
psychiatry [40–44]. Furthermore, there is also ‘currently
no accepted consensus on what constitutes positive out-
come for individuals with mental illness’ (where eradica-
tion of ‘symptoms’ does not always improve in parallel to
social functioning) [38].
Beyond this, it is also notable that the models and or-
ganisations that claim authority are invariably based in
high income countries (HICs), usually western, and that
the explanatory model of mental illness they articulate
is drawn from study of populations of usually high-
income countries. LMICs have a variety of different
ways of naming, understanding and responding to simi-
lar affective phenomena and often actively resist the
implementation of western models of mental health
[45]. Thus, many have questioned the assumptions em-
bedded in models that claim to be global, in particular
that they promote simplistic biomedical frameworks
disconnected from lived experience, and overlook indi-
genous forms of healing, social support networks and
rights-based organizing [36].
Many professionals make the case for a paradigm
change within psychiatry based on evidence that, in
summary, psychiatric diagnoses are not valid, do not aid
treatment decisions, impose Western beliefs about men-
tal distress on other cultures [35], may increase stigma
[46, 47], and are sites of institutional racism in many
multicultural HICs [48].
Wherever one is positioned within this debate it is in-
disputable that there is ongoing controversy about the
nature of mental illness, and whether the experiences it
describes can even be understood as “illnesses” at all.
This kind of debate is not the case with HIV/AIDS, or
even infectious disease more generally.
There are several further points of debate which serve
as reasons to be cautious about viewing mental health in
such universalizing ‘global’ terms. The ‘global’ approach
can overlook regional-level priorities and varying colonial
histories, and it can also obscure how global economic
and political forces, such as externally imposed neo-liberal
restructuring of economies and health systems, impact ex-
periences of mental health and well-being [49].
Rather than assuming that mental health is a universal
or global problem, much could be learned by the GMH
community from a more careful engagement with con-
temporary thinking on HIV/AIDS. Firstly, critical analysis
of HIV/AIDS has examined the ways that scales of local-
global are used to assert power, with influential ‘global’
movements framing particular disorders as ‘global’ to
shape the terms of intervention [50, 51]. Secondly, over
the last 20 years HIV/AIDS policy communities have be-
come increasingly nuanced in the ways in which they have
understood HIV/AIDS as ‘global’, shifting towards a much
more fine-grained understanding of the differences be-
tween the epidemics ongoing in different parts of the
world. As Wilson and Halperin argue:
The quest to better understand epidemics reflects
growing recognition that there is no single global HIV
epidemic, but rather a multitude of diverse epidemics.
No single prescription can apply to countries as diverse
as South Africa, Egypt, Russia, Thailand, or Papua New
Guinea. The era of standard global prevention guidance
is over. [52]
This insight could prove doubly relevant to the field of
mental health, which covers a significantly wider field of
disorders than that captured by HIV/AIDS and which
moreover (as already noted) lacks universal agreement
on the validity of psychiatric disorders, or even whether
the very notion of psychiatric disorders aptly captures
experiences of mental distress or differences in cognition.
Thus far, GMH advocacy appears to have failed to take
on board lessons concerning the move away from uni-
versalizing global guidance evident in the HIV/AIDS
case. Instead, global guidelines, such as the WHO’s
Mental Health Gap Action Programme (mhGAP) [53],
and algorithmic diagnostic tools, such as the WHO’s
mhGAP Intervention Guide [54], have been specifically
developed to aid treatment decisions in LMICs, and ac-
cording to advocates, ‘should become the standard ap-
proach for all countries and health sectors’ [55]. GMH
advocates have adopted a model of HIV advocacy based
on ‘globality’ that has since been questioned by HIV ad-
vocates, practitioners, and scholars in that field. A more
nuanced and up-to-date approach could fruitfully guide
GMH policy in a more localized direction.
Human rights and access to treatment
Human rights have been at the forefront of HIV/AIDS
advocacy. Yet as medicines for both HIV/AIDS and
‘mental illness’ have become embedded within global
and public health, some have commented on the rhetorical
slippage from the ‘right to health’ to a ‘right to access treat-
ment’ which implicitly equates health with consumption of
pharmaceuticals [56]. We question whether the ‘right to
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access treatment’ argument can be straightforwardly
imported from HIV/AIDS advocacy (where it has been
hugely influential) to mental health, especially on a global
scale.
One key early article written by three major MGMH
figures asserts that HIV advocates recognized the need
to argue that:
persons with HIV/AIDS in developing countries had
the right to access antiretroviral drugs, that the state
had to provide them for free, that drug companies
had to reduce their prices…that apparently complex
treatment regimens could be provided by primary
health care providers… These arguments were moral
and human rights based….We believe that the time is
ripe for such a global mental health advocacy
initiative that makes the moral case for the mentally
ill ([57], emphasis added).
This is rhetorically powerful but on closer inspection
difficulties arise, firstly in constructing the roll-out of
AIDS medicines purely as a matter of moral action, and
secondly in asserting that treatment for ‘mental illness’
can be similarly cast as a moral imperative.
First, this understanding of the prioritization of AIDS
as a victory for human rights advocacy glosses over the
fact that HIV/AIDS’ priority status was not entirely the
product of moral compulsion: US policy-makers were
concerned that high HIV prevalence in sub-Saharan Africa
(including in African militaries) could lead to state failure,
posing a threat to global stability and American national
security [58–60]. This framing of HIV as a military and se-
curity issue was an important contributor to a perceived
political imperative to tackle the pandemic. In some cases
this included prioritizing the health needs of military
actors.
Secondly, even in the case of HIV/AIDS, although it is
routine for advocates and organizations to talk in terms
of ‘prevention, treatment and care’, in practice treatment
(specifically the provision of antiretroviral medications)
has dominated policy and funding priorities. In low-
income countries in 2013, more than twice as much was
spent on treatment as prevention1 [61, 62]. The reasons
for this focus on treatment are varied, including success-
ful advocacy for the right to access treatment, growing
evidence for the effectiveness of treatment as prevention
[63], and a desire to avoid addressing the issues that in
many societies make prevention activities politically and
culturally sensitive [64]. In part, however, the focus on
treatment also reflects broader trends of medicalization
and pharmaceuticalization, in which drug-based solu-
tions are seen as the ‘go-to’ solution for pressing health
challenges [65], and healthcare rights are envisioned pri-
marily as being rights to those drugs.
Such a narrow view of human rights, borrowed from
the specific context of infectious disease, poses particular
problems in GMH, where there are significant ongoing
controversies concerning medicalization and pharma-
ceuticalization [66]. It is one thing to argue we might
learn something about how to advocate for GMH from
the history of advocacy for HIV/AIDS; it is another to
assume that solutions in one field are appropriate in
another. In the case of mental health, the problem may
not be lack of access to treatment but quite the reverse:
the right to access information about, and to refuse,
treatments - including medications that in some cases
have been found to be harmful, particularly long-term
[67, 44]. There is also evidence of widespread human
rights abuses within psychiatric institutions worldwide
(see, for example, see the work of Mental Disability
Rights International).
These rights abuses are sometimes recognized and
highlighted by GMH advocates, who argue that (for the
most part) care is better delivered within communities
not institutions. Yet many problems exist within com-
munity care which, in both the global North and South,
tends to be dominated by medication [68], sometimes
resulting in forced medicating and bio-incarceration [69]
and deprivations of legal capacity [70].
Globally, groups of psychiatric users and survivors,
and those who identify as psychosocially disabled or
mad positive, mobilize for: the right to have a choice in
how they are treated; the fundamental human right to
live independently and be included in the community es-
poused in Article 19 of the United Nations Convention
on the Rights of Persons with Disabilities (UNCRPD);
and the need for distress to be contextualized within so-
cial and economic conditions. See for example, the work
of Bapu Trust, India; the ‘Cape Town Declaration’ of the
Pan African Network of People with Psychosocial Disabil-
ities; the World Network of Users and Survivors of Psych-
iatry; and MindFreedom.
Despite some recognition by GMH advocates of the
social and economic determinants of mental distress, the
main assumption remains that mental health is a matter
of ‘illness’, similar to infectious disease, and the sug-
gested solution remains ‘global deployment of Western
biomedical models of mental disorder’, with community
participation and recovery conceptualised through a
narrow individualized medical framework [71]. This is
insufficient.
While the ‘right to treatment’ model has been import-
ant in global efforts to tackle HIV/AIDS, it is misleading
to assume it can be straightforwardly applied in the field
of GMH. A more nuanced lesson that may be learned
by looking at the struggles as well as the successes of
HIV/AIDS advocacy is that there are pitfalls to over-
emphasizing treatment in framing the human right to
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health. Since even in the realm of infectious disease
management, the emphasis on treatment has a propen-
sity to prioritize pharmaceutical solutions over invest-
ments in robust public health solutions and health
infrastructure, or tackling poverty as a social and eco-
nomic (rather than a primarily medical) issue.
Health, poverty and development
Relatedly, another debate concerning the applicability of
HIV lessons to global mental health concerns the nature
of the relationship between health, poverty and develop-
ment. The relationship between HIV/AIDS and poverty
has been portrayed as two-way; poverty exacerbates the
epidemic whilst the epidemic in turn worsens inequal-
ities [31]. HIV/AIDS advocates have made the case that
expanding access to HIV services is cost effective, has
macroeconomic benefits, and is a way to turn the ‘vicious
cycle’ of sickness and poverty into a ‘virtuous’ one of
wellbeing and economic progress [72].
The relationship between ‘mental illness’ and poverty
is also often framed as a ‘vicious cycle’: ‘mental health
problems are a brake on development as they cause (and
are caused by) poverty’ [11, 73–75]. In practice, however,
much of the focus of GMH advocates has been on how
preexisting mental health problems contribute to pov-
erty (rather than on how poverty leads to mental dis-
tress). Much GMH advocacy has argued that a high
prevalence of ‘mental disorder’ constitutes a barrier to
international development. Thornicroft and Patel [76],
drawing upon an influential study by Bloom et al. [12],
state that ‘people with untreated mental disorders have a
negative effect on global wealth’ through school and
work absenteeism, unemployment and healthcare costs,
and impaired productivity - ‘costing the world in excess
of $16tr (£9.5tr; €12tr) a year in lost economic output’.
Set against this cost, mental health treatments (especially
those based only on medications) look relatively cheap –
estimated at between $3–9 per capita [77].
Major international programs have proceeded based
on this logic of return on investment, such as the WHO
MIND (Mental Health in International Development)
and the UK Department for International Development
(DfID) MHaPP (Mental Health and Poverty Project)
[78]. In such programs, medical intervention is pitched
as a solution to poverty. Some have even suggested that
poverty alleviation efforts (such as microfinance) are less
effective than mental health treatments in breaking this
‘cycle’ [79].
Frameworks premised on a ‘vicious cycle’ tend to
prioritize economic arguments (the economic ‘burden’
of mental distress) over ones centered on justice [49]
and to focus on individual change rather than systemic
change as a means of tackling poverty. By positioning
mental distress as a barrier to economic development,
the current economic system is taken for granted and its
debilitating effects on mental health recast as ‘problems’
of individual brains. This enables psychiatric and psy-
chological expertise to be mobilized in relation to people
living in poverty, contributing to the psychologization
and psychiatrization of poverty.
Furthermore, attempts to measure the mental health
effects of poverty are problematic if they use tools based
on individual level global North diagnostic criteria,
which have been critiqued for reifying psychiatric diagnos-
tic categories that individualise distress and reconfigure
‘symptoms’ of oppression and inequality into ‘symptoms’
of mental disorder [80].
These concerns are doubly worthy of attention when
we acknowledge three profound ironies. First, that just
as largely medicalized mental health services and algo-
rithmic approaches to diagnoses (see [54]) are being
scaled up in the Global South, these same services are
coming under enormous criticism in the Global North
[35]. Second, that the WHO found better outcomes (as
defined by the WHO) for people diagnosed with Schizo-
phrenia in ‘developing’ countries, such as India and
Nigeria, than in high-income countries [81, 82]. Third,
that the deployment of economic-based arguments have
come in for heavy criticism from critical global health
scholars [83, 84] – not least as they have been applied to
HIV/AIDS [31]. As such, arguments that draw on the
history of HIV/AIDS to place individuals’ mental states
and psychology – rather than political or economic
systems – at the center of proposed solutions to global
inequality and poverty are worthy of skepticism.
De-Stigmatization, anti-discrimination, and social justice
GMH advocates argue that just as HIV advocates
fought for the de-stigmatization of people living with
HIV, so too should GMH initiatives foreground the de-
stigmatization of ‘mental illness’. However, the application
of the infectious disease model of de-stigmatization is de-
batable in the field of GMH, especially when it proceeds
without also incorporating anti-discrimination and social
justice work.
Combatting both stigma and discrimination has been
at the heart of HIV/AIDS advocacy since the 1980s, in
no small part as a result of pre-existing discrimination
against those who were (and continue to be) at higher
risk, including men who have sex with men, intravenous
drug users and sex workers. Advocates have often
highlighted the ways in which stigma can discourage
people from seeking testing and treatment; can lead to
social and economic isolation; and is connected with
broader systems of discrimination, such as homophobia
and criminalization.
Within GMH, stigma is understood as ‘problems of
knowledge (ignorance), attitudes (prejudice) and behaviour
Howell et al. Globalization and Health  (2017) 13:44 Page 6 of 9
(discrimination)’ [85] that act as barriers to treatment and
to mental health gaining policy traction [16]. GMH advo-
cates have noted that ‘knowledge about HIV/AIDS was
the most powerful tool to combat stigma’ [57]. By this
logic, knowledge about mental health is imagined to com-
bat stigma, where knowledge is understood through a dis-
ease model.
This framing shores up the authority of medical experts
to make decisions about people’s lives, and contradicts
user/survivor activism that seeks to destigmatize madness
as a form of difference, or to highlight the social and eco-
nomic contexts in which distress is produced.
Moreover, research has found that disease-based and
biological explanations for mental distress are more stig-
matizing and more likely to increase public desire for
distance than psychosocial explanations (such as distress
as response to trauma or difficult living conditions) [47].
Further, the disease analogy tends to emphasize the
de-stigmatization of disease (i.e. the idea that the ‘dis-
ease’ of ‘mental illness’ should not be stigmatized) above
all else. Anti-discrimination is pursued solely through at-
tempts to normalize mental disorder (often through em-
phasizing high prevalence) and to reduce, for example,
employment-based discrimination of those with a mental
health diagnosis.
While this focus is valuable, it is also insufficient.
GMH advocacy could learn from HIV activism concern-
ing de-stigmatization, anti-discrimination, and social
justice. HIV activists have historically taken a more hol-
istic approach, focused not only on discrimination on
the grounds of serostatus, but also the interconnected
nature of different forms of discrimination, including ra-
cism, homophobia and criminalization. This sort of
rounded approach to social justice is sorely needed in
mental health, given the well-documented racialization
and gendered nature of many mental health diagnoses,
and evidence of the institutional racism of psychiatry [48].
Imagine if GMH based its de-stigmatization work
in robust and holistic social justice frameworks,
opposing psychiatric incarceration, emphasizing self-
determination, and committing itself to tackling global
inequality as a matter of justice, rather than problem-
atizing individual behaviours of people living in poverty.
This might enable much wider structural forms of advo-
cacy around mental health, for example, by recognizing
not only work-based discrimination against mental dis-
order but also how free-market demands of limitless
growth, increased productivity and resultant unsafe and
insecure working conditions may lead to mental distress,
and so dedicating resources to opposing insecure work-
ing conditions as a kind of preventative action. Enhan-
cing the representation of people experiencing mental
distress would also be an important part of such a social
justice-based framework.
In answering the question ‘what can advocates of mental
health service transformation learn from the extraordinary
success of the HIV/AIDS advocacy movement?’, Burns
states that the first lesson is that successful advocacy
‘must, at its core, be represented and driven by ‘user
activists’ – that is, individuals living with HIV, mental
illness, etc’ [18]. In the HIV/AIDS field, the principle
of the Greater Involvement of People Living with HIV/
AIDS (GIPA) has been a much-vaunted accomplish-
ment [86, 87]. Whilst imperfectly applied in many in-
stances, the principle that People Living with HIV/
AIDS should be involved in decision-making at all
levels – from the local health facility up to global insti-
tutions – has done much to enhance both the quality
and the legitimacy of decision-making. It stands as an
example to GMH advocates of a practical way in which
steps towards greater justice can be pursued within
formal institutional arrangements.
Conclusions
What are the effects of adopting HIV/AIDS advocacy as
a model for GMH policy and action? What kinds of un-
derstanding and action does the analogy enable? Where
do we draw the line between making appropriate analo-
gies between GMH advocacy and HIV/AIDS advocacy,
and making inappropriate analogies between mental
health and HIV/AIDS? What version of HIV/AIDS ad-
vocacy is being adopted, and which facets of HIV/AIDS
activism are being ignored, simplified or miscast?
While much scholarly literature has assessed the merits
and potential problems with framing health issues in rela-
tion to social goods such as human rights, security, or de-
velopment, this article has debated the advantages and
disadvantages of framing health issues in relation to
each other, and specifically of importing models from
HIV/AIDS to make claims about mental health. Whilst
we have highlighted four crucial problems with this
framing, we have also argued HIV/AIDS advocacy can
provide GMH with both useful lessons and also some
cautionary tales. There is much to learn from a more
sustained and careful engagement between HIV and
GMH advocacy. Such an engagement would pay atten-
tion to the struggles of HIV/AIDS advocacy as well as
its successes, take into account issues of local/global
dynamics, human rights, poverty, anti-discrimination,
and justice, to name a few, and listen to the voices of
those with lived experience. Among the lessons it might
provide, we can suggest three:
First, we need to conceptualize disease and distress as
multiple and localized epidemics, responding differently
to distress linked to conflict, displacement, structural ad-
justment policies, amongst others. This is the current
conclusion of work within HIV/AIDS, and it seems even
more relevant to mental health, where there is a wide
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field of kinds and sources of distress, no (known) univer-
sal pathogen, no consensus on whether that distress is
an illness, and a plethora of different explanatory models
and methods of support globally. Second, we need to
move away from top-down global prescriptions and em-
phasise not only pharmaceutical solutions but also the
promotion of social justice and material well being.
Third, we need to promote meaningful non-tokenistic
involvement, leadership and decision-making of those
who have expertise through experience (such as users
and survivors).
With these lessons in mind, there is indeed great po-
tential for learning and cross-pollination of strategies
across communities struggling for and within systems of
global public health.
Endnotes
145% of HIV programme spending went on treatment,
as compared to 22% on prevention (17% went on‘pro-
gramme coordination’ and 16% on ‘other’)
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